CAPR · Capricor Therapeutics, Inc.
Market Cap
$546.51M
Shares
58.14M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 8-K | 2026-08-24 | — | |
| 10-Q | 2026-08-14 | 2026-06-30 | |
| 8-K | 2026-08-13 | — | |
| 8-K | 2026-07-30 | 2026-07-29 | |
| 8-K | 2026-07-29 | — | |
| 8-K | 2026-07-14 | 2026-07-09 | |
| Investor Event Transcript | 2026-06-30 | — | |
| 8-K | 2026-06-26 | — | |
| Investor Event Transcript | 2026-06-10 | 2026-06-30 | |
| 8-K | 2026-06-08 | 2026-06-04 | |
| 10-Q | 2026-05-13 | 2026-03-31 | |
| 8-K | 2026-05-12 | — | |
| 8-K | 2026-05-07 | — | |
| DEF 14A | 2026-04-10 | 2026-06-04 | |
| 10-K | 2026-03-17 | 2025-12-31 | |
| 8-K | 2026-03-12 | — | |
| 8-K | 2026-03-10 | — | |
| 8-K | 2025-12-05 | — | |
| 8-K | 2025-12-03 | — | |
| 8-K | 2025-12-03 | — | |
| 8-K | 2025-11-10 | — | |
| 10-Q | 2025-11-10 | 2025-09-30 | |
| 8-K | 2025-08-11 | — | |
| 10-Q | 2025-08-11 | 2025-06-30 | |
| 8-K | 2025-07-11 | — | |
| 8-K | 2025-05-27 | 2025-05-22 | |
| 10-Q | 2025-05-14 | 2025-03-31 | |
| 8-K | 2025-05-13 | — | |
| DEF 14A | 2025-04-08 | 2025-05-22 | |
| 8-K | 2025-04-08 | — | |
| 10-K | 2025-03-26 | 2024-12-31 | |
| 8-K | 2025-03-19 | — | |
| 8-K | 2025-03-04 | — | |
| 8-K | 2025-01-02 | — | |
| 10-Q | 2024-11-14 | 2024-09-30 | |
| 8-K | 2024-11-13 | — | |
| 8-K | 2024-10-17 | 2024-10-16 | |
| 8-K | 2024-10-16 | — | |
| 8-K | 2024-10-09 | — | |
| 8-K | 2024-09-24 | — | |
| 8-K | 2024-09-17 | 2024-09-16 | |
| 10-Q | 2024-08-08 | 2024-06-30 | |
| 8-K | 2024-08-07 | — | |
| 8-K | 2024-05-15 | 2024-05-14 | |
| 8-K | 2024-05-15 | 2024-05-14 | |
| 10-Q | 2024-05-14 | 2024-03-31 | |
| 8-K | 2024-05-13 | — | |
| 8-K | 2024-04-29 | — | |
| DEF 14A | 2024-04-01 | 2024-05-14 | |
| 10-K | 2024-03-11 | 2023-12-31 |
Showing 1–50 of 122 filings
Key facts
CIK
1133869
CUSIP
14070B309
13F (30d)
145 filings
145 filers
Visit website
Investor relations